• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Lifemed and EXL to Transform Healthcare Revenue Cycle Management into Revenue Cycle Automation

    6/8/26 4:17:00 PM ET
    $EXLS
    Real Estate
    Real Estate
    Get the next $EXLS alert in real time by email

    MIAMI, June 8, 2026 /PRNewswire/ -- Paying healthcare providers is far from straightforward. Frequent policy changes, complex contracts, and diverse payment methods make reimbursement a moving target. Traditional rules-based systems can't keep pace with today's data volume or easily adapt to evolving requirements, leaving many organizations stuck with manual fixes, delays, rising administrative costs, and shrinking margins as denials continue to increase across the industry.

    To address these challenges, EXL is collaborating with Lifemed to disrupt and advance modern revenue cycle management (RCM) through AI-powered automation. Instead of relying on generic industry datasets, their AI capabilities use deep learning to analyze a provider's unique historical data. This adaptive solution processes medical, contractual, and financial data in real time, transforming RCM from a reactive process into a proactive one by identifying errors, automating compliance checks, optimizing billing codes, and autonomously managing denials and appeals with minimal human intervention prior to submitting the claim to the payer. As a result, healthcare provider organizations can accelerate reimbursements, increase revenue, and free up staff to focus on complex, high-risk cases.

    "At EXL, we're thrilled to collaborate with Lifemed to deliver a truly differentiated solution that redefines how providers handle their revenue cycle," said Trevor Jares, vice president of Integrated Revenue Management Solutions at EXL. "By integrating intelligence, automation, and real-time insights, we're driving a more efficient, next-generation approach to claims management – from submission through adjudication – we will be able to arm providers with a technology that will deliver a significant positive impact on their margins."

    "Our collaboration with EXL represents a major leap in revenue cycle innovation," said Darian Rodriguez, executive vice president of Revenue Cycle Automation at Lifemed. "Together, we can accelerate the adoption of smarter, more efficient RCM workflows that shift operations from reactive error correction to proactive prevention aided by our Deepclaim neural network AI real-time pre-adjudication capabilities, helping providers recover more revenue, operate at maximum efficiency, and focus on delivering better care outcomes."

    This solution boosts financial performance, decreases denials, and optimizes the revenue cycle, delivering 10–25% higher net revenue, cutting accounts receivables (AR) days by 30% or more and reducing related staffing workload by over 80%.

    Contact us to discover how you can empower your data to achieve faster, more accurate payments with a risk-free assessment and 90-day pilot – now available and conducted live in your environment at no cost.

    About Lifemed

    Lifemed is a healthcare technology company redefining revenue cycle management through AI-powered automation. Its flagship platform, Deepclaim, leverages a proprietary deep learning neural network to analyze a provider's unique historical data in real time — automating compliance checks, optimizing billing codes, and autonomously managing denials and appeals before claims ever reach the payer. Unlike traditional rules-based systems, Deepclaim adapts continuously to evolving payer policies and contract complexity, transforming revenue cycle operations from reactive error correction to proactive prevention. Lifemed's solutions have delivered measurable outcomes for health systems nationwide, including significant improvements in net patient service revenue, reductions in AR days, and decreased administrative overhead. Learn more at lifemed.ai.

    About EXL

    EXL (NASDAQ:EXLS) is a global data and AI company that offers services and solutions to reinvent client business models, drive better outcomes and unlock growth with speed. EXL harnesses the power of data, AI, and deep industry knowledge to transform businesses, including the world's leading corporations in industries including insurance, healthcare, banking and capital markets, retail, communications and media, and energy and infrastructure, among others. EXL was founded in 1999 with the core values of innovation, collaboration, excellence, integrity and respect. We are headquartered in New York and have approximately 67,000 employees spanning six continents. For more information, visit www.exlservice.com.

    Cision View original content:https://www.prnewswire.com/news-releases/lifemed-and-exl-to-transform-healthcare-revenue-cycle-management-into-revenue-cycle-automation-302794391.html

    SOURCE Life Med, Inc.

    Get the next $EXLS alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $EXLS

    DatePrice TargetRatingAnalyst
    9/9/2024$35.00 → $42.00Hold → Buy
    Jefferies
    5/8/2024$34.00 → $40.00Neutral → Outperform
    Wedbush
    1/17/2024$29.00 → $36.00Neutral → Buy
    Citigroup
    9/19/2023$33.00Hold
    Jefferies
    3/15/2023$160.00Sell → Neutral
    Citigroup
    7/29/2022$190.00Hold → Buy
    Needham
    7/20/2022$150.00 → $134.00Neutral → Sell
    Citigroup
    3/1/2022$132.00 → $143.00Neutral → Buy
    BofA Securities
    More analyst ratings

    $EXLS
    SEC Filings

    View All

    SEC Form SCHEDULE 13G filed by ExlService Holdings Inc.

    SCHEDULE 13G - ExlService Holdings, Inc. (0001297989) (Subject)

    5/14/26 12:01:52 PM ET
    $EXLS
    Real Estate

    ExlService Holdings Inc. filed SEC Form 8-K: Leadership Update, Other Events, Financial Statements and Exhibits

    8-K - ExlService Holdings, Inc. (0001297989) (Filer)

    5/12/26 8:10:26 AM ET
    $EXLS
    Real Estate

    SEC Form 10-Q filed by ExlService Holdings Inc.

    10-Q - ExlService Holdings, Inc. (0001297989) (Filer)

    4/28/26 4:15:24 PM ET
    $EXLS
    Real Estate

    $EXLS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    ExlService upgraded by Jefferies with a new price target

    Jefferies upgraded ExlService from Hold to Buy and set a new price target of $42.00 from $35.00 previously

    9/9/24 7:33:07 AM ET
    $EXLS
    Real Estate

    ExlService upgraded by Wedbush with a new price target

    Wedbush upgraded ExlService from Neutral to Outperform and set a new price target of $40.00 from $34.00 previously

    5/8/24 7:28:26 AM ET
    $EXLS
    Real Estate

    ExlService upgraded by Citigroup with a new price target

    Citigroup upgraded ExlService from Neutral to Buy and set a new price target of $36.00 from $29.00 previously

    1/17/24 7:14:18 AM ET
    $EXLS
    Real Estate

    $EXLS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Lifemed and EXL to Transform Healthcare Revenue Cycle Management into Revenue Cycle Automation

    MIAMI, June 8, 2026 /PRNewswire/ -- Paying healthcare providers is far from straightforward. Frequent policy changes, complex contracts, and diverse payment methods make reimbursement a moving target. Traditional rules-based systems can't keep pace with today's data volume or easily adapt to evolving requirements, leaving many organizations stuck with manual fixes, delays, rising administrative costs, and shrinking margins as denials continue to increase across the industry. To address these challenges, EXL is collaborating with Lifemed to disrupt and advance modern revenue cycle management (RCM) through AI-powered automation. Instead of relying on generic industry datasets, their AI capabil

    6/8/26 4:17:00 PM ET
    $EXLS
    Real Estate

    EXL announces integration with NVIDIA Transaction Foundation Model workflow to help financial institutions build next-generation AI for fraud, risk and transaction intelligence

    NEW YORK, June 04, 2026 (GLOBE NEWSWIRE) -- EXL (NASDAQ:EXLS), a global data and AI company, announced the integration of NVIDIA's Build Your Own Transaction Foundation Model developer example into its AI and analytics offerings, enabling financial institutions to rapidly build and deploy transaction intelligence applications powered by their own proprietary data. As banks, payments firms and insurers move beyond fragmented, task-specific AI models, EXL is helping clients operationalize unified, transformer-based transaction models across fraud detection, risk management, personalization and recommendation use cases. Built on NVIDIA's accelerated computing platform, the Build Your Own Tr

    6/4/26 11:54:20 AM ET
    $EXLS
    Real Estate

    BetterInvesting™ Magazine Update on Netflix (NASDAQ: NFLX) and ExlService Holdings Inc. (NASDAQ: EXLS)

    TROY, Mich., May 22, 2026 /PRNewswire/ -- Netflix Inc's recent report has investors wondering if the company's stock is fairly valued. Or is it in the buy range? As such, the Editorial Advisory and Securities Review Committee of BetterInvesting Magazine considers Netflix (NASDAQ:NFLX) as worthy of further study and has named the company its "Stock to Study" for the August 2026 issue for investors' informational and educational use. The fundamental data is eye-opening; investors can view Netflix's sales, earnings, pre-tax profit, return on equity, and more all on one page, courtesy of the National Association of Investors Corp., at:  https://ssg.betterinvesting.org/trial/ssgplus/?studyid.A fu

    5/22/26 4:30:00 PM ET
    $EXLS
    $NFLX
    Real Estate
    Consumer Electronics/Video Chains
    Consumer Discretionary

    $EXLS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President of EXL Bhalla Vikas sold $362,640 worth of shares (12,000 units at $30.22) as part of a pre-agreed trading plan, decreasing direct ownership by 7% to 153,295 units (SEC Form 4)

    4 - ExlService Holdings, Inc. (0001297989) (Issuer)

    6/8/26 4:20:43 PM ET
    $EXLS
    Real Estate

    EVP & Gen Counsel/Corp. Sec'y. Ayyappan Ajay sold $148,257 worth of shares (5,093 units at $29.11), decreasing direct ownership by 9% to 48,994 units (SEC Form 4)

    4 - ExlService Holdings, Inc. (0001297989) (Issuer)

    5/22/26 4:31:17 PM ET
    $EXLS
    Real Estate

    SEC Form 3 filed by new insider Singh Bhupender

    3 - ExlService Holdings, Inc. (0001297989) (Issuer)

    5/13/26 9:03:05 PM ET
    $EXLS
    Real Estate

    $EXLS
    Leadership Updates

    Live Leadership Updates

    View All

    EXL appoints Bhupender Singh as President and Head of International Growth Markets

    NEW YORK, May 12, 2026 (GLOBE NEWSWIRE) -- EXL (NASDAQ:EXLS), a global data and AI company, announced the appointment of Bhupender Singh as president and head of international growth markets. He will report to Rohit Kapoor, chairman and chief executive officer of EXL and will be an executive committee member. In this role, Singh will serve as the head of international growth markets for EXL and take the lead in accelerating growth for the EMEA and APAC regions. He will be responsible for architecting go-to-market strategies for diverse economies, uniting cross-cultural teams under a single high-performance banner and establishing EXL as the premier data and AI partner in these markets. "

    5/12/26 8:01:00 AM ET
    $EXLS
    Real Estate

    Data and AI Leader EXL to host 'IdeaTank' innovation event at the Nasdaq MarketSite

    More than 11,000 pitch ideas submitted from EXL employees globally Shark Tank's Robert Herjavec to join EXL IdeaTank event NEW YORK, Nov. 25, 2025 (GLOBE NEWSWIRE) -- EXL (NASDAQ:EXLS), a global data and AI company, announced that it will hold its second annual IdeaTank event at the Nasdaq MarketSite on December 8, 2025. A celebration of EXL's innovation-at-speed culture and AI-native workforce, the event features new data and AI pitch ideas submitted from EXL's global employee base. Winning ideas receive funding and fast-track development resources to launch new capabilities and breakthrough client solutions. Now in its second year, the 2025 IdeaTank has received more than 11,000 submi

    11/25/25 2:26:35 PM ET
    $EXLS
    Real Estate

    EXL announces appointment of Patrick Geraghty to Board of Directors

    NEW YORK, Oct. 20, 2025 (GLOBE NEWSWIRE) -- EXL (NASDAQ:EXLS), a global data and AI company, announced that Patrick "Pat" Geraghty, a seasoned chief executive with a strong record of innovation across the healthcare industry, has been appointed to EXL's Board of Directors as an independent director effective October 20, 2025. Geraghty will be a member of the board's audit and nominating and governance committees. Chairman and Chief Executive Officer Rohit Kapoor said, "We are delighted to welcome Pat to the board. His years of experience leading large healthcare payer organizations will provide us with invaluable insights and perspectives as we continue to rapidly support our clients' nee

    10/20/25 8:13:00 AM ET
    $EXLS
    Real Estate

    $EXLS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by ExlService Holdings Inc.

    SC 13G/A - ExlService Holdings, Inc. (0001297989) (Subject)

    11/12/24 9:55:17 AM ET
    $EXLS
    Real Estate

    SEC Form SC 13G/A filed by ExlService Holdings Inc. (Amendment)

    SC 13G/A - ExlService Holdings, Inc. (0001297989) (Subject)

    2/9/24 9:03:02 AM ET
    $EXLS
    Real Estate

    SEC Form SC 13G/A filed by ExlService Holdings Inc. (Amendment)

    SC 13G/A - ExlService Holdings, Inc. (0001297989) (Subject)

    2/8/24 10:20:08 AM ET
    $EXLS
    Real Estate

    $EXLS
    Financials

    Live finance-specific insights

    View All

    EXL Reports 2026 First Quarter Results

    2026 First Quarter Revenue of $570.4 Million, up 13.8% year-over-yearQ1 Diluted EPS (GAAP) of $0.43, up 5.7% from $0.40 in Q1 of 2025Q1 Adjusted Diluted EPS (Non-GAAP) (1) of $0.58, up 20.2% from $0.48 in Q1 of 2025 NEW YORK, April 28, 2026 (GLOBE NEWSWIRE) -- ExlService Holdings, Inc. (NASDAQ:EXLS), a global data and AI company, today announced its financial results for the quarter ended March 31, 2026. Chairman and Chief Executive Officer Rohit Kapoor said, "We entered 2026 with strong momentum, delivering revenue growth of 14% and increased our adjusted diluted EPS by 20% year-over-year. Our sustained double-digit growth demonstrates the strength of our competitive position as well as

    4/28/26 4:01:00 PM ET
    $EXLS
    Real Estate

    EXL Schedules First Quarter 2026 Financial Results Conference Call

    NEW YORK, April 08, 2026 (GLOBE NEWSWIRE) -- ExlService Holdings, Inc. (NASDAQ:EXLS), a global data and AI company, will release financial results for the first quarter ended March 31, 2026, on Tuesday, April 28, 2026, after the market closes. An earnings news release, investor fact sheet and presentation will be published on the company's investor relations website offering an overview of the financial results. The company will host a conference call at 10:00 a.m. EDT the following day, Wednesday, April 29, 2026, with Chairman and Chief Executive Officer Rohit Kapoor and Executive Vice President and Chief Financial Officer Maurizio Nicolelli, who will provide insights into the company's

    4/8/26 8:01:00 AM ET
    $EXLS
    Real Estate

    EXL Reports 2025 Fourth Quarter and Year-End Results; Issues 2026 Guidance

    2025 Fourth Quarter Revenue of $542.6 Million, up 12.7% year-over-yearQ4 Diluted EPS (GAAP) of $0.38, up 21.8% from $0.31 in Q4 of 2024Q4 Adjusted Diluted EPS (Non-GAAP) (1) of $0.50, up 15.0% from $0.44 in Q4 of 2024 2025 Revenue of $2.09 Billion, up 13.6% year-over-year2025 Diluted EPS (GAAP) of $1.54, up 28.0% from $1.21 in 20242025 Adjusted Diluted EPS (Non-GAAP) (1) of $1.95, up 18.0% from $1.65 in 2024 NEW YORK, Feb. 24, 2026 (GLOBE NEWSWIRE) -- ExlService Holdings, Inc. (NASDAQ:EXLS), a global data and AI company, today announced its financial results for the quarter and full year ended December 31, 2025. Chairman and Chief Executive Officer Rohit Kapoor said, "I am pleased to r

    2/24/26 4:01:00 PM ET
    $EXLS
    Real Estate